A review on the evolving environment of medical device real-world evidence regulation on market access in the USA.
作者信息
Shi Lizheng, Xuan Dennis, Jakovljevic Mihajlo
机构信息
School of Public Health and Tropical Medicine, Health Systems Analytics Research Center, Tulane University, New Orleans, LA, USA.
UNESCO-The World Academy of Sciences TWAS, Trieste, 34100, Italy.
出版信息
Cost Eff Resour Alloc. 2024 Oct 25;22(1):75. doi: 10.1186/s12962-024-00582-9.
Abstract
摘要
相似文献
1
A review on the evolving environment of medical device real-world evidence regulation on market access in the USA.美国医疗器械真实世界证据监管在市场准入方面的不断演变环境综述。
Cost Eff Resour Alloc. 2024 Oct 25;22(1):75. doi: 10.1186/s12962-024-00582-9.
2
Real-world data to support post-market safety and performance of embolization coils: evidence generation from a medical device manufacturer and data institute partnership.支持栓塞线圈上市后安全性和性能的真实世界数据：医疗器械制造商和数据研究所合作产生的证据。
BMC Med Inform Decis Mak. 2024 Sep 19;24(1):263. doi: 10.1186/s12911-024-02659-0.
3
The value of using real-world evidence as a source of clinical evidence in the European medical device regulations: a mixed methods study.利用真实世界证据作为欧洲医疗器械法规临床证据来源的价值：混合方法研究。
Expert Rev Med Devices. 2024 Jan-Feb;21(1-2):149-163. doi: 10.1080/17434440.2023.2291454. Epub 2024 Feb 4.
4
The Evolving Landscape of Medical Device Regulation in East, Central, and Southern Africa.东、中、南部非洲医疗器械监管的演变格局。
Glob Health Sci Pract. 2021 Mar 31;9(1):136-148. doi: 10.9745/GHSP-D-20-00578.
5
Requirements to bring a medical device to market.医疗器械上市的要求。
Trends Biotechnol. 2025 Jan;43(1):4-7. doi: 10.1016/j.tibtech.2024.07.016. Epub 2024 Aug 23.
6
Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.心血管医学中的器械创新：欧洲心脏病学会心血管圆桌会议报告。
Eur Heart J. 2024 Apr 1;45(13):1104-1115. doi: 10.1093/eurheartj/ehae069.
7
Will the EU Medical Device Regulation help to improve the safety and performance of medical AI devices?欧盟医疗器械法规会有助于提高医疗人工智能设备的安全性和性能吗？
Digit Health. 2022 Mar 30;8:20552076221089079. doi: 10.1177/20552076221089079. eCollection 2022 Jan-Dec.
8
Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments.欧洲和美国心血管设备市场授权的对比临床证据：基于奥地利预报销评估对10种设备的系统分析
BMC Cardiovasc Disord. 2014 Nov 4;14:154. doi: 10.1186/1471-2261-14-154.
9
Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring.可穿戴式心脏监测智能设备的监管、法律和市场方面
Sensors (Basel). 2021 Jul 20;21(14):4937. doi: 10.3390/s21144937.
10
[Discuss Application of Real-world Data from the Boao Lecheng Pilot Zone to Support Premarket Clinical Evaluation of Medical Device].[探讨博鳌乐城先行区真实世界数据在医疗器械上市前临床评价中的应用]
Zhongguo Yi Liao Qi Xie Za Zhi. 2023 Jan 30;47(1):83-88. doi: 10.3969/j.issn.1671-7104.2023.01.015.
本文引用的文献
1
Development of the China's list of ambulatory care sensitive conditions (ACSCs): a study protocol.中国门诊医疗敏感条件（ACSCs）清单的制定：一项研究方案。
Glob Health Res Policy. 2024 Mar 19;9(1):11. doi: 10.1186/s41256-024-00350-5.
2
Real-world evidence for regulatory decision-making: updated guidance from around the world.用于监管决策的真实世界证据：来自世界各地的最新指南。
Front Med (Lausanne). 2023 Oct 30;10:1236462. doi: 10.3389/fmed.2023.1236462. eCollection 2023.
3
Strategic management and organizational culture of medical device companies in relation to corporate performance.医疗器械公司的战略管理和组织文化与企业绩效的关系。
J Med Econ. 2023 Jan-Dec;26(1):781-792. doi: 10.1080/13696998.2023.2224168.
4
Evidence-based objective performance criteria for the evaluation of hip and knee replacement devices and technologies.基于证据的髋关节和膝关节置换装置和技术的客观绩效评估标准。
Int J Surg. 2023 May 1;109(5):1125-1135. doi: 10.1097/JS9.0000000000000169.
5
Access and reimbursement pathways for digital health solutions and diagnostic devices: Current scenario and challenges.数字健康解决方案和诊断设备的准入与报销途径：现状与挑战
Front Med Technol. 2023 Feb 20;5:1101476. doi: 10.3389/fmedt.2023.1101476. eCollection 2023.
6
Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks.通过协调注册网络推进医疗器械的真实世界证据
BMJ Surg Interv Health Technol. 2022 Nov 11;4(Suppl 1):e000123. doi: 10.1136/bmjsit-2021-000123. eCollection 2022.
7
Real-world data: a brief review of the methods, applications, challenges and opportunities.真实世界数据：方法、应用、挑战和机遇的简要回顾。
BMC Med Res Methodol. 2022 Nov 5;22(1):287. doi: 10.1186/s12874-022-01768-6.
8
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.协调方案模板以提高治疗效果的真实世界证据研究中假说评估的可重复性：ISPE/ISPOR 联合工作组的良好实践报告。
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):44-55. doi: 10.1002/pds.5507. Epub 2022 Oct 10.
9
Health technology assessment of medical devices: current landscape, challenges, and a way forward.医疗器械的卫生技术评估：现状、挑战及未来方向。
Cost Eff Resour Alloc. 2022 Oct 5;20(1):54. doi: 10.1186/s12962-022-00389-6.
10
Post-market surveillance of medical devices: A review.医疗器械上市后监测：综述。
Technol Health Care. 2022;30(6):1315-1329. doi: 10.3233/THC-220284.
Zotero 插件